Arrowstreet Capital, Limited Partnership Astrazeneca PLC Transaction History
Arrowstreet Capital, Limited Partnership
- $120 Billion
- Q1 2025
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Astrazeneca PLC stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 3,591,620 shares of AZN stock, worth $254 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
3,591,620
Previous 1,117,094
221.51%
Holding current value
$254 Million
Previous $73.2 Million
260.68%
% of portfolio
0.22%
Previous 0.06%
Shares
29 transactions
Others Institutions Holding AZN
# of Institutions
1,427Shares Held
505MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.04 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.88 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.52 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.25 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.22 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $219B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...